Search Results - "Niu, Qing‐Tian"
-
1
Tissue‐Level Mechanisms Responsible for the Increase in Bone Formation and Bone Volume by Sclerostin Antibody
Published in Journal of bone and mineral research (01-06-2014)“…ABSTRACT Bone formation can be remodeling‐based (RBF) or modeling‐based (MBF), the former coupled to bone resorption and the latter occurring directly on…”
Get full text
Journal Article -
2
Sclerostin Antibody Treatment Increases Bone Formation, Bone Mass, and Bone Strength in a Rat Model of Postmenopausal Osteoporosis
Published in Journal of bone and mineral research (01-04-2009)“…The development of bone‐rebuilding anabolic agents for potential use in the treatment of bone loss conditions, such as osteoporosis, has been a long‐standing…”
Get full text
Journal Article -
3
Targeted Deletion of the Sclerostin Gene in Mice Results in Increased Bone Formation and Bone Strength
Published in Journal of bone and mineral research (01-06-2008)“…Introduction: Sclerosteosis is a rare high bone mass genetic disorder in humans caused by inactivating mutations in SOST, the gene encoding sclerostin. Based…”
Get full text
Journal Article -
4
Sustained Modeling‐Based Bone Formation During Adulthood in Cynomolgus Monkeys May Contribute to Continuous BMD Gains With Denosumab
Published in Journal of bone and mineral research (01-07-2015)“…ABSTRACT Denosumab (DMAb) administration to postmenopausal women with osteoporosis is associated with continued bone mineral density (BMD) increases and low…”
Get full text
Journal Article -
5
Kinetic reconstruction reveals time-dependent effects of romosozumab on bone formation and osteoblast function in vertebral cancellous and cortical bone in cynomolgus monkeys
Published in Bone (New York, N.Y.) (01-08-2017)“…Abstract Romosozumab, a humanized monoclonal sclerostin antibody under development for the treatment of osteoporosis, has a unique mechanism of action on…”
Get full text
Journal Article -
6
Sclerostin is expressed in articular cartilage but loss or inhibition does not affect cartilage remodeling during aging or following mechanical injury
Published in Arthritis & rheumatology (Hoboken, N.J.) (01-03-2013)“…Objective Sclerostin plays a major role in regulating skeletal bone mass, but its effects in articular cartilage are not known. The purpose of this study was…”
Get full text
Journal Article -
7
Inhibition of sclerostin by monoclonal antibody increases bone formation, bone mass, and bone strength in aged male rats
Published in Journal of bone and mineral research (01-12-2010)“…The purpose of this study was to evaluate the effects of sclerostin inhibition by treatment with a sclerostin antibody (Scl‐AbII) on bone formation, bone mass,…”
Get full text
Journal Article -
8
FGF21 Is Not a Major Mediator for Bone Homeostasis or Metabolic Actions of PPARα and PPARγ Agonists
Published in Journal of bone and mineral research (01-04-2017)“…ABSTRACT Results of prior studies suggest that fibroblast growth factor 21 (FGF21) may be involved in bone turnover and in the actions of peroxisome…”
Get full text
Journal Article -
9
Effects of various pine needle extracts on Chinese hamster ovary cell growth and monoclonal antibody quality
Published in Preparative biochemistry & biotechnology (03-10-2023)“…Chinese hamster ovary (CHO) cells are commonly used as "bio-machines" to pro-duce monoclonal antibodies (mAb) because of their ability to produce very complex…”
Get full text
Journal Article -
10
Sclerostin Antibody Reverses Bone Loss by Increasing Bone Formation and Decreasing Bone Resorption in a Rat Model of Male Osteoporosis
Published in Endocrinology (Philadelphia) (01-01-2018)“…Sclerostin antibody (Scl-Ab) restored bone mass and strength in the ovariectomized rat model of postmenopausal osteoporosis. Increased bone mineral density…”
Get full text
Journal Article -
11
Temporal changes in systemic and local expression of bone turnover markers during six months of sclerostin antibody administration to ovariectomized rats
Published in Bone (New York, N.Y.) (01-10-2014)“…Abstract Sclerostin (Scl) is an osteocyte protein that decreases bone formation, and its inhibition by neutralizing antibodies (Scl-Ab) increases bone…”
Get full text
Journal Article -
12
Journal of Bone and Mineral Research: Volume 30, Issue 5, May 2015, Frontmatter page ii
Published in Journal of bone and mineral research (01-07-2015)Get full text
Journal Article -
13
Atm-deficient mice: an osteoporosis model with defective osteoblast differentiation and increased osteoclastogenesis
Published in Human molecular genetics (15-06-2006)“…Atm is a Ser/Thr kinase involved in DNA damage response and is required for genome integrity and stem cell renewal. Here, we report an additional role for Atm…”
Get full text
Journal Article -
14
One Year of Transgenic Overexpression of Osteoprotegerin in Rats Suppressed Bone Resorption and Increased Vertebral Bone Volume, Density, and Strength
Published in Journal of bone and mineral research (01-07-2009)“…RANKL is an essential mediator of bone resorption, and its activity is inhibited by osteoprotegerin (OPG). Transgenic (Tg) rats were engineered to continuously…”
Get full text
Journal Article -
15
Progressive Increases in Bone Mass and Bone Strength in an Ovariectomized Rat Model of Osteoporosis After 26 Weeks of Treatment With a Sclerostin Antibody
Published in Endocrinology (Philadelphia) (01-12-2014)“…The effects of up to 26 weeks of sclerostin antibody (Scl-Ab) treatment were investigated in ovariectomized (OVX) rats. Two months after surgery, 6-month-old…”
Get full text
Journal Article -
16
Etelcalcetide (AMG 416), a peptide agonist of the calcium-sensing receptor, preserved cortical bone structure and bone strength in subtotal nephrectomized rats with established secondary hyperparathyroidism
Published in Bone (New York, N.Y.) (01-12-2017)“…Sustained elevation of parathyroid hormone (PTH) is catabolic to cortical bone, as evidenced by deterioration in bone structure (cortical porosity), and is a…”
Get full text
Journal Article -
17
A possible role for melanocortin peptides in longitudinal growth
Published in Journal of endocrinology (01-12-2006)“…Clinical and in vitro data suggest a link between the elevation of the melanocortin peptide, ACTH, and longitudinal growth. Overproduction of ACTH in familial…”
Get full text
Journal Article -
18
Increased Bone Formation and Bone Mass Induced by Sclerostin Antibody Is Not Affected by Pretreatment or Cotreatment with Alendronate in Osteopenic, Ovariectomized Rats
Published in Endocrinology (Philadelphia) (01-09-2011)“…Clinical studies have revealed a blunting of the bone anabolic effects of parathyroid hormone treatment in osteoporotic patients in the setting of pre- or…”
Get full text
Journal Article -
19
Increased callus mass and enhanced strength during fracture healing in mice lacking the sclerostin gene
Published in Bone (New York, N.Y.) (01-12-2011)“…Abstract Humans with inherited sclerostin deficiency have high bone mass. Targeted deletion of the sclerostin gene in mice (SOST-KO) causes increases in bone…”
Get full text
Journal Article -
20
Increased RANK ligand in bone marrow of orchiectomized rats and prevention of their bone loss by the RANK ligand inhibitor osteoprotegerin
Published in Bone (New York, N.Y.) (01-10-2009)“…Abstract Orchiectomized (ORX) rats were used to examine the extent to which their increased bone resorption and decreased bone density might relate to…”
Get full text
Journal Article